UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 392

Sortiert nach

Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas

Nature communications, 2015-01, Vol.6 (1), Article 6140

2015

Volltextzugriff (PDF)

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

Nature (London), 2017-06, Vol.546 (7658), p.431-435

2017

Volltextzugriff (PDF)

Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

Cell, 2019-08, Vol.178 (4), p.933-948.e14

2019

Volltextzugriff (PDF)

A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer

Cancer cell, 2014-09, Vol.26 (3), p.344-357

2014

Volltextzugriff (PDF)

BRCA1/2 mutations and de novo hematologic malignancies: true, true and not clearly related

Haematologica (Roma), 2024-01, Vol.109 (1), p.21

2024

Volltextzugriff (PDF)

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

American journal of human genetics, 2016-05, Vol.98 (5), p.801-817

2016

Volltextzugriff (PDF)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Nature communications, 2017-08, Vol.8 (1), p.319-11, Article 319

2017

Volltextzugriff (PDF)

CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing

Genome Biology, 2018-11, Vol.19 (1), p.202-202, Article 202

2018

Volltextzugriff (PDF)

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)

Genetics in medicine, 2020-07, Vol.22 (7), p.1142-1148

2020

Volltextzugriff (PDF)

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background

Cancer genetics, 2012-01, Vol.205 (1), p.1-11

2012

Volltextzugriff (PDF)

A human breast atlas integrating single-cell proteomics and transcriptomics

Developmental cell, 2022-06, Vol.57 (11), p.1400-1420.e7

2022

Volltextzugriff (PDF)

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Clinical cancer research, 2019-07, Vol.25 (14), p.4363-4374

2019

Volltextzugriff (PDF)

PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (7), p.2750-2760

2011

Volltextzugriff (PDF)

Immunotherapy at large: the road to personalized cancer vaccines

Nature medicine, 2013-09, Vol.19 (9), p.1098-1100

2013

Volltextzugriff (PDF)

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood

Clinical cancer research, 2017-07, Vol.23 (13), p.e107-e114

2017

Volltextzugriff (PDF)

Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target

Clinical cancer research, 2014-11, Vol.20 (21), p.5537-5546

2014

Volltextzugriff (PDF)

Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer

Cancer immunology research, 2018-03, Vol.6 (3), p.276-287

2018

Volltextzugriff (PDF)

Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer

Nature genetics, 2009-07, Vol.41 (7), p.811-815

2009

Volltextzugriff (PDF)

Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

Clinical cancer research, 2017-07, Vol.23 (13), p.e123-e132

2017

Volltextzugriff (PDF)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Nature communications, 2022-11, Vol.13 (1), p.6728-6728, Article 6728

2022

Volltextzugriff (PDF)

The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel

Clinical cancer research, 2008-01, Vol.14 (1), p.230-239

2008

Volltextzugriff (PDF)

Lower abdominal and pelvic radiation and testicular germ cell tumor risk

PloS one, 2020-11, Vol.15 (11), p.e0239321

2020

Volltextzugriff (PDF)

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Nature medicine, 2011-08, Vol.17 (8), p.941-943

2011

Volltextzugriff (PDF)

HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (34), p.14391-14396

2009

Volltextzugriff (PDF)

The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling

PloS one, 2013-03, Vol.8 (3), p.e59588

2013

Volltextzugriff (PDF)

1 – 25 von 392

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(373)
Mit Volltextzugriff
(356)

Publikationsform

Sprache

Englisch
(391)
Japanisch
(51)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer

BRCA1/2 mutations and de novo hematologic malignancies: true, true and not clearly related

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background

A human breast atlas integrating single-cell proteomics and transcriptomics

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

Immunotherapy at large: the road to personalized cancer vaccines

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood

Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target

Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer

Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer

Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel

Lower abdominal and pelvic radiation and testicular germ cell tumor risk

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses

The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling

Suchergebnisse filtern